MetaCap

Neumora Therapeutics Statistics

NASDAQ: NMRAHealthcareBiotechnologyUSD

0.4798+0.0115 (+2.46%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Neumora Therapeutics by the numbers

Neumora Therapeutics has a market capitalization of $90.2 million based on 187.90M shares outstanding. With trailing EPS of $-1.23, Neumora Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 59.4% below its 50-day average and 74.8% below its 200-day average.

Average daily trading volume is 1.19M shares, or about $571,990 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

NMRA valuation vs. peer median

NMRA compared with the median of 8 peer companies
MetricNMRAPeer medianDifference
Market cap$90.15M$89.46M+1%
Avg. volume1.19M162.11K+635%

Peer median across 8 companies: RLYB, EQ, MIST, ICCC, ATRA, OKUR, CGTX, NRXS.

Valuation

Market cap
$90.15M
P/E (TTM)
—
Forward P/E
—
EPS (TTM)
$-1.23
Shares outstanding
187.90M

Price and trading

Previous close
0.4683
Open
0.4634
Day range
0.451 – 0.4861
52-week range
0.45 – 3.65
52-week change
-75.27%
50-day moving average
1.18
200-day moving average
1.90
Beta
—
Volume
1.79M
Average volume
1.19M

Dividends and events

Annual dividend
None
Dividend yield
—
Ex-dividend date
—
Next earnings date
Nov 5, 2026

Additional statistics

Market Cap
90.15M
Forward Pe
-0.72
Eps
-1.23
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.65
Week52 Low
0.45
Avg Volume
1.19M
Shares Outstanding
187.90M
Ma50
1.18
Ma200
1.90
Earnings Date
Nov 5, 2026
Pct From52w High
-86.85%
Pct From52w Low
6.62%

Related